Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125269031 | 12526903 | 1 | I | 20160606 | 20160705 | 20160705 | PER | US-PFIZER INC-2016290176 | PFIZER | 0.00 | F | Y | 0.00000 | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125269031 | 12526903 | 1 | PS | ATROPINE SULFATE. | ATROPINE SULFATE | 1 | U | 17106 | |||||||||||
| 125269031 | 12526903 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | U | 77245 | ||||||||||
| 125269031 | 12526903 | 3 | SS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | UNK | U | 50162 | CAPSULE, HARD | |||||||||
| 125269031 | 12526903 | 4 | SS | DOXYCYCLINE MONOHYDRATE | DOXYCYCLINE | 1 | UNK | U | 50006 | POWDER FOR ORAL SUSPENSION | |||||||||
| 125269031 | 12526903 | 5 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | U | 74133 | ||||||||||
| 125269031 | 12526903 | 6 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | U | 19999 | ||||||||||
| 125269031 | 12526903 | 7 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | U | 19787 | FILM-COATED TABLET | |||||||||
| 125269031 | 12526903 | 8 | SS | PHENYTOIN. | PHENYTOIN | 1 | UNK | U | 8762 | ||||||||||
| 125269031 | 12526903 | 9 | SS | VERAPAMIL HCL | VERAPAMIL HYDROCHLORIDE | 1 | UNK | U | 18817 | ||||||||||
| 125269031 | 12526903 | 10 | SS | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 11 | SS | CEFACLOR. | CEFACLOR | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 12 | SS | CODEINE | CODEINE | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 13 | SS | CHLORDIAZEPOXIDE HCL | CHLORDIAZEPOXIDE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 14 | SS | CLONIDINE. | CLONIDINE | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 15 | SS | DESLORATADINE. | DESLORATADINE | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 16 | SS | FACTIVE | GEMIFLOXACIN MESYLATE | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 17 | SS | IODINE. | IODINE | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 18 | SS | KEFLEX | CEPHALEXIN | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 19 | SS | MONISTAT 1 COMBINATION PACK | MICONAZOLE NITRATE | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 20 | SS | SULTRIN | SULFABENZAMIDESULFACETAMIDESULFATHIAZOLE | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 21 | SS | TARKA | TRANDOLAPRILVERAPAMIL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 22 | SS | TETANUS TOXOID ADSORBED | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 1 | UNK | U | 0 | ||||||||||
| 125269031 | 12526903 | 23 | SS | VALIUM | DIAZEPAM | 1 | U | 0 | |||||||||||
| 125269031 | 12526903 | 24 | SS | TIOCONAZOLE. | TIOCONAZOLE | 1 | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125269031 | 12526903 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |